Peter W. de Leeuw, MD
de Leeuw PW. Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs. Ann Intern Med. 2013;158:JC7. doi: 10.7326/0003-4819-158-6-201303190-02007
Download citation file:
Published: Ann Intern Med. 2013;158(6):JC7.
Cardiology, Chronic Kidney Disease, Coronary Risk Factors, Diabetes, Diabetic Nephropathy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use